Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BioRestorative Therapies, Inc.BRTX · Entity 8277 | Director | August 27, 2019 | August 29, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BioRestorative Therapies, Inc.
Report date August 27, 2019 · Filed August 29, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 24,500 |
Ending reported balance
After 2019-08-28 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-08-27 · Purchase · Acquired 3,000 · Balance 21,500 Row 2 · 2019-08-28 · Purchase · Acquired 3,000 · Balance 24,500 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.75 · Expires 2022-02-09 | Direct | 30,000 |
Reported balance
Holding disclosure · report date 2019-08-27 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 30,000 F1: The option is exercisable to the extent of 15,000 shares on each of February 10, 2012 and February 10, 2013. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.75 · Expires 2022-12-07 | Direct | 5,000 |
Reported balance
Holding disclosure · report date 2019-08-27 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 5,000 F2: The option is exercisable to the extent of 2,500 shares on each of December 7, 2012 and December 7, 2013. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.75 · Expires 2023-10-04 | Direct | 12,500 |
Reported balance
Holding disclosure · report date 2019-08-27 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 12,500 F3: The option is exercisable to the extent of 6,250 shares on each of October 4, 2013 and October 4, 2014. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.75 · Expires 2024-02-18 | Direct | 25,000 |
Reported balance
Holding disclosure · report date 2019-08-27 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 25,000 F4: The option is exercisable to the extent of 8,334 shares on February 18, 2014, and 8,333 shares on each of February 18, 2015 and February 18, 2016. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.75 · Expires 2024-10-23 | Direct | 50,000 |
Reported balance
Holding disclosure · report date 2019-08-27 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 50,000 F5: The option is exercisable to the extent of 16,667 shares on each of October 23, 2015 and Octobe 23, 2016 and 16,666 shares on October 23, 2017. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.75 · Expires 2025-09-04 | Direct | 115,500 |
Reported balance
Holding disclosure · report date 2019-08-27 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 115,500 F6: The option is exercisable to the extent of 57,750 shares on December 22, 2015, and 19,250 shares on each of September 4, 2016, September 4, 2017 and September 4, 2018. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.75 · Expires 2026-06-10 | Direct | 128,000 |
Reported balance
Holding disclosure · report date 2019-08-27 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 128,000 F7: The option is exercisable to the extent of 42,667 shares on each of June 10, 2016 and June 10, 2017, and 42,666 shares on June 10, 2018. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.75 · Expires 2027-06-23 | Direct | 125,000 |
Reported balance
Holding disclosure · report date 2019-08-27 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 125,000 F8: The option is exercisable to the extent of 41,667 shares on each of June 23, 2017 and June 23, 2018, and 41,666 shares on June 23, 2019. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.75 · Expires 2028-10-29 | Direct | 75,000 |
Reported balance
Holding disclosure · report date 2019-08-27 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 75,000 F9: The option is exercisable to the extent of 25,000 shares on each of October 29, 2018, October 29, 2019 and October 29, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: The option is exercisable to the extent of 15,000 shares on each of February 10, 2012 and February 10, 2013.
F2: The option is exercisable to the extent of 2,500 shares on each of December 7, 2012 and December 7, 2013.
F3: The option is exercisable to the extent of 6,250 shares on each of October 4, 2013 and October 4, 2014.
F4: The option is exercisable to the extent of 8,334 shares on February 18, 2014, and 8,333 shares on each of February 18, 2015 and February 18, 2016.
F5: The option is exercisable to the extent of 16,667 shares on each of October 23, 2015 and Octobe 23, 2016 and 16,666 shares on October 23, 2017.
F6: The option is exercisable to the extent of 57,750 shares on December 22, 2015, and 19,250 shares on each of September 4, 2016, September 4, 2017 and September 4, 2018.
F7: The option is exercisable to the extent of 42,667 shares on each of June 10, 2016 and June 10, 2017, and 42,666 shares on June 10, 2018.
F8: The option is exercisable to the extent of 41,667 shares on each of June 23, 2017 and June 23, 2018, and 41,666 shares on June 23, 2019.
F9: The option is exercisable to the extent of 25,000 shares on each of October 29, 2018, October 29, 2019 and October 29, 2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 28, 2019 Filed Aug 29, 2019 20:20 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 3,000 | $0.28 | $840.00 |
DisclosureSEC source: 0001567619-19-017677 · doc1.xml · nonDerivative · entry 2 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,500 Read SEC document |
| August 27, 2019 Filed Aug 29, 2019 20:20 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 3,000 | $0.27 | $809.70 |
DisclosureSEC source: 0001567619-19-017677 · doc1.xml · nonDerivative · entry 1 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,500 Read SEC document |
| August 26, 2019 Filed Aug 27, 2019 21:19 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 3,000 | $0.25 | $750.00 |
DisclosureSEC source: 0001567619-19-017605 · doc1.xml · nonDerivative · entry 2 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,500 Read SEC document |
| August 23, 2019 Filed Aug 27, 2019 21:19 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | PurchaseCommon Stock | 3,000 | $0.26 | $789.60 |
DisclosureSEC source: 0001567619-19-017605 · doc1.xml · nonDerivative · entry 1 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,500 Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 22:47 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantStock Option · Derivative | 75,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007599 · doc1.xml · derivative · entry 19 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2028-10-29 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F9 · derivative.exercise_date: The option is exercisable to the extent of 25,000 shares on each of October 29, 2018, October 29, 2019 and October 29, 2020. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 22:47 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | Disposition to issuerStock Option · Derivative | 75,000 | Not disclosed Strike: $1.23 | Not disclosed |
DisclosureSEC source: 0001567619-19-007599 · doc1.xml · derivative · entry 18 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 75,000 shares Expires 2028-10-29 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F9 · derivative.exercise_date: The option is exercisable to the extent of 25,000 shares on each of October 29, 2018, October 29, 2019 and October 29, 2020. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 22:47 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantStock Option · Derivative | 125,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007599 · doc1.xml · derivative · entry 17 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2027-06-23 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F8 · derivative.exercise_date: The option is exercisable to the extent of 41,667 shares on each of June 23, 2017 and June 23, 2018, and 41,666 shares on June 23, 2019. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 22:47 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | Disposition to issuerStock Option · Derivative | 125,000 | Not disclosed Strike: $3.35 | Not disclosed |
DisclosureSEC source: 0001567619-19-007599 · doc1.xml · derivative · entry 16 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 125,000 shares Expires 2027-06-23 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F8 · derivative.exercise_date: The option is exercisable to the extent of 41,667 shares on each of June 23, 2017 and June 23, 2018, and 41,666 shares on June 23, 2019. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 22:47 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantStock Option · Derivative | 128,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007599 · doc1.xml · derivative · entry 15 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,000 Underlying: Common Stock · 128,000 shares Expires 2026-06-10 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F7 · derivative.exercise_date: The option is exercisable to the extent of 42,667 shares on each of June 10, 2016 and June 10, 2017, and 42,666 shares on June 10, 2018. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 22:47 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | Disposition to issuerStock Option · Derivative | 128,000 | Not disclosed Strike: $3.73 | Not disclosed |
DisclosureSEC source: 0001567619-19-007599 · doc1.xml · derivative · entry 14 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 128,000 shares Expires 2026-06-10 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F7 · derivative.exercise_date: The option is exercisable to the extent of 42,667 shares on each of June 10, 2016 and June 10, 2017, and 42,666 shares on June 10, 2018. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 22:47 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantStock Option · Derivative | 115,500 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007599 · doc1.xml · derivative · entry 13 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,500 Underlying: Common Stock · 115,500 shares Expires 2025-09-04 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F6 · derivative.exercise_date: The option is exercisable to the extent of 57,750 shares on December 22, 2015, and 19,250 shares on each of September 4, 2016, September 4, 2017 and September 4, 2018. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 22:47 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | Disposition to issuerStock Option · Derivative | 115,500 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007599 · doc1.xml · derivative · entry 12 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 115,500 shares Expires 2025-09-04 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F6 · derivative.exercise_date: The option is exercisable to the extent of 57,750 shares on December 22, 2015, and 19,250 shares on each of September 4, 2016, September 4, 2017 and September 4, 2018. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 22:47 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantStock Option · Derivative | 50,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007599 · doc1.xml · derivative · entry 11 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2024-10-23 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F5 · derivative.exercise_date: The option is exercisable to the extent of 16,667 shares on each of October 23, 2015 and Octobe 23, 2016 and 16,666 shares on October 23, 2017. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 22:47 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | Disposition to issuerStock Option · Derivative | 50,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007599 · doc1.xml · derivative · entry 10 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2024-10-23 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F5 · derivative.exercise_date: The option is exercisable to the extent of 16,667 shares on each of October 23, 2015 and Octobe 23, 2016 and 16,666 shares on October 23, 2017. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 22:47 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantStock Option · Derivative | 25,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007599 · doc1.xml · derivative · entry 9 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2024-02-18 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F4 · derivative.exercise_date: The option is exercisable to the extent of 8,334 shares on February 18, 2014, and 8,333 shares on each of February 18, 2015 and February 18, 2016. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 22:47 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | Disposition to issuerStock Option · Derivative | 25,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007599 · doc1.xml · derivative · entry 8 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2024-02-18 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F4 · derivative.exercise_date: The option is exercisable to the extent of 8,334 shares on February 18, 2014, and 8,333 shares on each of February 18, 2015 and February 18, 2016. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 22:47 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantStock Option · Derivative | 12,500 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007599 · doc1.xml · derivative · entry 7 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2023-10-04 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F3 · derivative.exercise_date: The option is exercisable to the extent of 6,250 shares on each of October 4, 2013 and October 4, 2014. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 22:47 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | Disposition to issuerStock Option · Derivative | 12,500 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007599 · doc1.xml · derivative · entry 6 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2023-10-04 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F3 · derivative.exercise_date: The option is exercisable to the extent of 6,250 shares on each of October 4, 2013 and October 4, 2014. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 22:47 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantStock Option · Derivative | 5,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007599 · doc1.xml · derivative · entry 5 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2022-12-07 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F2 · derivative.exercise_date: The option is exercisable to the extent of 2,500 shares on each of December 7, 2012 and December 7, 2013. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 22:47 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | Disposition to issuerStock Option · Derivative | 5,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007599 · doc1.xml · derivative · entry 4 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2022-12-07 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F2 · derivative.exercise_date: The option is exercisable to the extent of 2,500 shares on each of December 7, 2012 and December 7, 2013. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 22:47 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantStock Option · Derivative | 30,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001567619-19-007599 · doc1.xml · derivative · entry 3 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2022-02-09 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F1 · derivative.exercise_date: The option is exercisable to the extent of 15,000 shares on each of February 10, 2012 and February 10, 2013. Read SEC document |
| March 25, 2019 Filed Mar 25, 2019 22:47 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | Disposition to issuerStock Option · Derivative | 30,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001567619-19-007599 · doc1.xml · derivative · entry 2 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2022-02-09 F10 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F1 · derivative.exercise_date: The option is exercisable to the extent of 15,000 shares on each of February 10, 2012 and February 10, 2013. Read SEC document |
| October 29, 2018 Filed Oct 31, 2018 20:03 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantStock Option · Derivative | 75,000 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001567619-18-004865 · doc1.xml · derivative · entry 10 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2028-10-29 F9 · derivative.exercise_date: The option is exercisable to the extent of 25,000 shares on each of October 29, 2018, October 29, 2019 and October 29, 2020. Read SEC document |
| June 23, 2017 Filed Jun 26, 2017 20:57 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantStock Option · Derivative | 125,000 | $0.00 Strike: $3.35 | $0.00 |
DisclosureSEC source: 0001140361-17-026102 · doc1.xml · derivative · entry 9 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2027-06-23 F8 · derivative.exercise_date: The option is exercisable to the extent of 41,667 shares on each of June 23, 2017 and June 23, 2018, and 41,666 shares on June 23, 2019. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:36 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantStock Option · Derivative | 115,500 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007717 · doc1.xml · derivative · entry 13 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,500 Underlying: Common Stock · 115,500 shares Expires 2025-09-04 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F6 · derivative.exercise_date: The option is exercisable to the extent of 57,750 shares on December 22, 2015, and 19,250 shares on each of September 4, 2016, September 4, 2017 and September 4, 2018. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:36 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | Disposition to issuerStock Option · Derivative | 115,500 | Not disclosed Strike: $7.00 | Not disclosed |
DisclosureSEC source: 0001140361-17-007717 · doc1.xml · derivative · entry 12 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 115,500 shares Expires 2025-09-04 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F6 · derivative.exercise_date: The option is exercisable to the extent of 57,750 shares on December 22, 2015, and 19,250 shares on each of September 4, 2016, September 4, 2017 and September 4, 2018. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:36 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantStock Option · Derivative | 50,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007717 · doc1.xml · derivative · entry 11 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2024-10-23 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F5 · derivative.exercise_date: The option is exercisable to the extent of 16,667 shares on each of October 23, 2015 and Octobe 23, 2016 and 16,666 shares on October 23, 2017. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:36 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | Disposition to issuerStock Option · Derivative | 50,000 | Not disclosed Strike: $6.60 | Not disclosed |
DisclosureSEC source: 0001140361-17-007717 · doc1.xml · derivative · entry 10 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2024-10-23 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F5 · derivative.exercise_date: The option is exercisable to the extent of 16,667 shares on each of October 23, 2015 and Octobe 23, 2016 and 16,666 shares on October 23, 2017. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:36 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantStock Option · Derivative | 25,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007717 · doc1.xml · derivative · entry 9 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2024-02-18 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F4 · derivative.exercise_date: The option is exercisable to the extent of 8,334 shares on February 18, 2014, and 8,333 shares on each of February 18, 2015 and February 18, 2016. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:36 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | Disposition to issuerStock Option · Derivative | 25,000 | Not disclosed Strike: $13.00 | Not disclosed |
DisclosureSEC source: 0001140361-17-007717 · doc1.xml · derivative · entry 8 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2024-02-18 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F4 · derivative.exercise_date: The option is exercisable to the extent of 8,334 shares on February 18, 2014, and 8,333 shares on each of February 18, 2015 and February 18, 2016. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:36 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantStock Option · Derivative | 12,500 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007717 · doc1.xml · derivative · entry 7 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2023-10-04 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F3 · derivative.exercise_date: The option is exercisable to the extent of 6,250 shares on each of October 4, 2013 and October 4, 2014. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:36 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | Disposition to issuerStock Option · Derivative | 12,500 | Not disclosed Strike: $12.00 | Not disclosed |
DisclosureSEC source: 0001140361-17-007717 · doc1.xml · derivative · entry 6 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2023-10-04 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F3 · derivative.exercise_date: The option is exercisable to the extent of 6,250 shares on each of October 4, 2013 and October 4, 2014. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:36 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantStock Option · Derivative | 5,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007717 · doc1.xml · derivative · entry 5 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2022-12-07 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F2 · derivative.exercise_date: The option is exercisable to the extent of 2,500 shares on each of December 7, 2012 and December 7, 2013. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:36 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | Disposition to issuerStock Option · Derivative | 5,000 | Not disclosed Strike: $30.00 | Not disclosed |
DisclosureSEC source: 0001140361-17-007717 · doc1.xml · derivative · entry 4 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2022-12-07 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F2 · derivative.exercise_date: The option is exercisable to the extent of 2,500 shares on each of December 7, 2012 and December 7, 2013. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:36 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | GrantStock Option · Derivative | 30,000 | Not disclosed Strike: $4.70 | Not disclosed |
DisclosureSEC source: 0001140361-17-007717 · doc1.xml · derivative · entry 3 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2022-02-09 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F1 · derivative.exercise_date: The option is exercisable to the extent of 15,000 shares on each of February 10, 2012 and February 10, 2013. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 21:36 UTC | BioRestorative Therapies, Inc. BRTX · Entity 8277 | Disposition to issuerStock Option · Derivative | 30,000 | Not disclosed Strike: $21.00 | Not disclosed |
DisclosureSEC source: 0001140361-17-007717 · doc1.xml · derivative · entry 2 Radov A. Jeffrey · CIK 0001528040 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2022-02-09 F8 · price: The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option at a reduced exercise price. F1 · derivative.exercise_date: The option is exercisable to the extent of 15,000 shares on each of February 10, 2012 and February 10, 2013. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.